Status:
COMPLETED
Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA
Lead Sponsor:
Illumina, Inc.
Conditions:
Detection and Genotyping of Factor V and Factor II Point Mutations
Eligibility:
All Genders
Brief Summary
As an external validation test of the performance of the VeraCode Genotyping Test for Factor V and Factor II on the BeadXpress System, clinical trials will be conducted at three sites. This study will...
Eligibility Criteria
Inclusion
- Patient samples will be leftover EDTA-anticoagulated whole blood from patients referred for Factor V and/or Factor II testing.
Exclusion
- There are no applicable exclusion criteria for this test, since the genomic sequence will not vary by ethnicity, gender, age or disease. Inappropriately stored blood samples will be excluded.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT00959504
Start Date
August 1 2009
End Date
September 1 2009
Last Update
June 9 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.